GlobeNewswire Inc.··NaAnteris Lands Medicare Reimbursement for PARADIGM Heart Valve Trial
Anteris Technologies secures CMS reimbursement eligibility for its PARADIGM Trial evaluating DurAVR transcatheter heart valve in 1,000 patients, accelerating U.S. site activation.
AVRclinical trialPARADIGM Trial